-
Risk-directed childhood leukemia treatment takes a step forward
04/10/2021
St. Jude findings highlight genomic analysis as a tool to extend risk-directed therapy and improve outcomes for children with the most common pediatric cancer.
-
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
04/07/2021
Results from a collaborative multi-site clinical trial show the success of adding brentuximab vedotin, reducing radiation.
-
Martine Roussel, Ph.D., elected to the AACR Academy Class of 2021
03/30/2021
Martine Roussel, Ph.D., has been elected to the 2021 Class of Fellows of the American Association for Cancer Research.
-
Signals from muscle protect from dementia
03/26/2021
Scientists at St. Jude are studying how signals sent from skeletal muscle affect the brain.
-
ATRT molecular groups: looking at the biology from the clinic
03/18/2021
Scientists at St. Jude Children’s Research Hospital are learning more about what the molecular groups of a rare pediatric brain tumor mean for clinical care.
-
St. Jude receives $9.9 million to advance cures for hard-to-treat pediatric cancer
03/17/2021
St. Jude scientists have been selected for an international collaborative research effort to advance treatment for some leading causes of childhood cancer death.
-
Delaying the first spinal tap may lower risk of pediatric leukemia relapse
03/15/2021
An international research team has identified clinical factors associated with the risk of central nervous system relapse in patients with the most common childhood cancer.
-
St. Jude and Washington University researchers receive $3.1 million NIH grant
03/04/2021
Five-year grant will aid in the study of mechanisms underlying neurodegenerative diseases like ALS.
-
St. Jude launches program to boost HPV cancer prevention across the globe
03/04/2021
St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming.
-
Socioeconomic status plays a major role in cognitive outcomes
03/01/2021
St. Jude scientists are studying the risk factors associated with cancer treatments and its effects on cognition.
Explore more research news
More Research News
-
Scientific Report 2020
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Promise Magazine
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.